PITTSBURGH–(BUSINESS WIRE)–Rinovum® Women’s Health announced today that The Stork®
OTC—the only home-use conception assistance device on the market cleared
by the FDA for over-the-counter sales—was featured on a recent episode
of the Emmy Award-winning daytime talk show The Doctors. The
episode, showcasing innovative, medical products, aired Friday, October 9th,
Starting a family is one of the most important times in a couple’s life.
For some, getting pregnant is easy; however, for approximately 7.3
million people it is not so simple: one in six US couples experience
difficulty conceiving due to infertility1. The
pathway to parenthood can be an extremely taxing time, both emotionally
and financially, often leaving couples feeling out of control. The Stork
OTC is an innovative device that offers couples a relaxed and private
way of using cervical cap insemination – an established, effective
conception technique previously available only by prescription – to help
with becoming pregnant. It is the only FDA-cleared product that provides
consumers a safe, easy way to perform this technique by themselves, at
“This product is $80, compared to if you go to your Doctor and your
insurance doesn’t cover IVF, or any type of fertility treatment you
could end up paying a lot. So it’s worth a shot…the whole idea is kind
of like a modified version of the turkey baster…but what you’re doing
that is different, is you’re putting this cervical cap in…and you let
the sperm “marinate” at the cervix…It keeps everything right at the
cervix to help increase your chances of getting pregnant,” said Dr.
Rachael Ross, during the aired segment.
The Stork OTC uses a “condom-like” sheath for the collection of sperm
and an easy-to-use “tampon-like applicator” which delivers the cervical
cap of sperm close to the cervical opening. Cervical cap insemination
has a recorded success rate of around 20%2,3, which is
comparable to IUI – with recorded success rates between 16-21%4.
Watch the full video on how The Stork OTC works here.
“The Stork OTC is an easy-to-use, logical, cost-effective way to take
control and optimize your chances to conceive at home,” said Stephen
Bollinger, President and CEO of Rinovum Women’s Health, and
co-creator of the device. “This product has helped many couples get
closer to their goal of building a family. We are excited to bring
greater awareness to the many women and couples that are still trying.”
Who Can Use The Stork OTC?
The Stork OTC can help people optimize their chances of conceiving,
- People who are trying to become pregnant.
- Men diagnosed with low sperm count or motility issues.
- Women diagnosed with an unfavorable vaginal environment (pH imbalance).
- Couples trying to become pregnant without intercourse.
Couples who are not ready to take the next step in reproductive
treatment such as IUI or IVF.
The Stork OTC is available for purchase at select retailers nationwide,
and online. Visit www.storkotc.com
for online sales and store locations. The device was cleared by the FDA
for over-the-counter sales in July 2014, and made available to the
market in September of 2014. The product is available for sale as The
Stork in the United Kingdom, Australia, and Canada.
1National Institutes of Health, National Institute of Child
Health and Human Development; http://www.nichd.nih.gov/health/topics/infertility/conditioninfo/Pages/common.aspx
”Therapeutic donor insemination: A prospective randomized trial of fresh
versus frozen sperm.” Leslee L. Subak, MD, G. David Adamson, MD, Nancy
L. Boltz, RNC. American Journal of Obstetrics & Gynecology, Volume 166,
Issue 6, Part 1, June 1992. http://www.ncbi.nlm.nih.gov/m/pubmed/1615966/
”The cervical cap for home artificial insemination.” Corson SL,
Batzer FR, Otis C, Fee, D. Journal of Reproductive Medicine, May 1986;
American Society for Reproductive Medicine: http://www.reproductivefacts.org/FACTSHEET_Intrauterine_Insemination_IUI/
About Rinovum Women’s Health
Rinovum Women’s Health is a privately held women’s health company
dedicated to bringing products into the market that will enhance women’s
lives and empower them to take charge of their health. The Stork
Ib2C, Inc., A Rinovum Women’s Health Company, launched its flagship
product, The Stork® OTC, which is a conception aid for reproductive
health to assist in natural fertility and conception in the privacy of
the patient’s home. For more information about Rinovum Women’s Health,
The Stork Ib2C, Inc., and The Stork OTC, visit www.rinovum.com
Rinovum® Women’s Health
Brianna Freeman, 724-241-8936